New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Mirum Pharmaceuticals, Inc.
MIRM
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 06 May 2025

2B

Biotechnology

Next Earning date - 06 May 2025

52.17USD

Shape-0.53 ( -1.01%)
Market Open
favorite-chart

Relative Strenght

93
favorite-chart

Volume Buzz

24%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

4%

Quote Panel

Shape
Updated March 24, 2025
1W 7.18 % 1M -4.89 % 3M 12.99 % 1Y 81.68 %

Key Metrics

Shape
  • Market Cap

    2.33B


  • Shares Outstanding

    49.01M


  • Share in Float

    38.93M


  • Dividende

    0


  • Earning Date

    06 May 2025


  • Price Target

    47.61


  • Average Volume

    518210


  • Beta

    1.042


  • Range

    23.14-54.234


  • Industry

    Biotechnology


  • Website

    https://www.mirumpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

MIRM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$428M

Shape330%

2025-Revenue

$0.92

Shape-89%

2025-EPS

$161M

Shape-991%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.80
vs -1.17

Q2.23

arrow
arrow

N/A

-0.92
vs -0.84

Q3.23

arrow
arrow

N/A

-0.57
vs -1.02

Q4.23

arrow
arrow

N/A

-0.66
vs -0.99

Q1.24

arrow
arrow

N/A

-0.54
vs -0.80

Q2.24

arrow
arrow

N/A

-0.52
vs -0.92

Q3.24

arrow
arrow

N/A

-0.30
vs -0.57

Q4.24

arrow
arrow

N/A

-0.49
vs -0.66

Q1.25

arrow
arrow

N/A

-0.31
vs -0.54

Q2.25

arrow
arrow

N/A

-0.27
vs -0.52

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+145%

31.6M  vs 12.9M

Q2.23

arrow
arrow

+114%

37.5M  vs 17.5M

Q3.23

arrow
arrow

+154%

47.7M  vs 18.8M

Q4.23

arrow
arrow

+149%

69.6M  vs 27.9M

Q1.24

arrow
arrow

+119%

69.2M  vs 31.6M

Q2.24

arrow
arrow

+108%

77.9M  vs 37.5M

Q3.24

arrow
arrow

+89%

90.4M  vs 47.7M

Q4.24

arrow
arrow

+43%

99.4M  vs 69.6M

Q1.25

arrow
arrow

+42%

98M  vs 69.2M

Q2.25

arrow
arrow

+33%

103.6M  vs 77.9M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-21%

-0.21
vs 0.09

Q2.23

arrow
arrow

+15%

0.15
vs -0.21

Q3.23

arrow
arrow

-9%

-0.09
vs 0.15

Q4.23

arrow
arrow

-13%

-0.13
vs -0.09

Q1.24

arrow
arrow

-11%

-0.11
vs -0.13

Q2.24

arrow
arrow

-11%

-0.11
vs -0.11

Q3.24

arrow
arrow

-6%

-0.06
vs -0.11

Q4.24

arrow
arrow

-11%

-0.11
vs -0.06

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

117

117
vs 103

14%

Q2.23

arrow
arrow

147

147
vs 117

26%

Q3.23

arrow
arrow

160

160
vs 147

9%

Q4.23

arrow
arrow

191

191
vs 160

19%

Q1.24

arrow
arrow

175

175
vs 191

-8%

Q2.24

arrow
arrow

166

166
vs 175

-5%

Q3.24

arrow
arrow

184

184
vs 166

11%

Q4.24

arrow
arrow

205

205
vs 184

11%

Earnings Growth

Latest News